Kidswell Bio Corporation (TYO:4584)
Japan
· Delayed Price · Currency is JPY 251.00
-28.00 (-10.04%)
Jul 1, 2025, 3:30 PM JST
Kidswell Bio Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2015 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2015 - 2018 |
Operating Revenue | 4,930 | 1,569 | 996 | 1,077 | 1,022 | Upgrade
|
Other Revenue | 152 | - | - | - | - | Upgrade
|
| 5,082 | 1,569 | 996 | 1,077 | 1,022 | Upgrade
| |
Revenue Growth (YoY) | 223.90% | 57.53% | -7.52% | 5.41% | -3.59% | Upgrade
|
Cost of Revenue | 3,649 | 551 | 120 | 654 | 412.39 | Upgrade
|
Gross Profit | 1,433 | 1,018 | 876 | 423 | 609.32 | Upgrade
|
Selling, General & Admin | 638 | 787 | 883 | 687 | 468.96 | Upgrade
|
Research & Development | 767 | 1,150 | 963 | 898 | 945.23 | Upgrade
|
Operating Expenses | 1,405 | 1,937 | 1,846 | 1,585 | 1,414 | Upgrade
|
Operating Income | 28 | -919 | -970 | -1,162 | -805.17 | Upgrade
|
Interest Expense | -42 | -15 | -15 | -5 | - | Upgrade
|
Interest & Investment Income | - | - | - | - | 0.12 | Upgrade
|
Currency Exchange Gain (Loss) | -2 | -9 | -3 | -1 | -8.34 | Upgrade
|
Other Non Operating Income (Expenses) | 17 | -11 | -5 | -19 | -2.63 | Upgrade
|
EBT Excluding Unusual Items | 1 | -954 | -993 | -1,187 | -816.02 | Upgrade
|
Gain (Loss) on Sale of Investments | 35 | 417 | -7 | -145 | - | Upgrade
|
Gain (Loss) on Sale of Assets | 4 | 2 | 1 | - | - | Upgrade
|
Asset Writedown | -6 | - | -1 | -5,982 | -0.4 | Upgrade
|
Other Unusual Items | 39 | 1 | - | - | -37.98 | Upgrade
|
Pretax Income | 73 | -534 | -1,000 | -7,314 | -854.39 | Upgrade
|
Income Tax Expense | 94 | 1 | 1 | 2 | 1.9 | Upgrade
|
Net Income | -21 | -535 | -1,001 | -7,316 | -856.29 | Upgrade
|
Net Income to Common | -21 | -535 | -1,001 | -7,316 | -856.29 | Upgrade
|
Shares Outstanding (Basic) | 41 | 31 | 29 | 28 | 20 | Upgrade
|
Shares Outstanding (Diluted) | 41 | 31 | 29 | 28 | 20 | Upgrade
|
Shares Change (YoY) | 31.28% | 7.16% | 4.14% | 41.55% | 2.06% | Upgrade
|
EPS (Basic) | -0.52 | -17.34 | -34.77 | -264.64 | -43.84 | Upgrade
|
EPS (Diluted) | -0.52 | -17.34 | -34.77 | -264.64 | -43.84 | Upgrade
|
Free Cash Flow | 930 | -1,169 | -1,267 | -1,326 | -860.32 | Upgrade
|
Free Cash Flow Per Share | 22.96 | -37.89 | -44.01 | -47.97 | -44.05 | Upgrade
|
Gross Margin | 28.20% | 64.88% | 87.95% | 39.28% | 59.64% | Upgrade
|
Operating Margin | 0.55% | -58.57% | -97.39% | -107.89% | -78.81% | Upgrade
|
Profit Margin | -0.41% | -34.10% | -100.50% | -679.29% | -83.81% | Upgrade
|
Free Cash Flow Margin | 18.30% | -74.51% | -127.21% | -123.12% | -84.20% | Upgrade
|
EBITDA | - | -917 | - | -1,162 | -804.85 | Upgrade
|
EBITDA Margin | - | -58.45% | - | -107.86% | -78.77% | Upgrade
|
D&A For EBITDA | - | 2 | - | 0.32 | 0.32 | Upgrade
|
EBIT | 28 | -919 | -970 | -1,162 | -805.17 | Upgrade
|
EBIT Margin | 0.55% | -58.57% | -97.39% | -107.89% | -78.81% | Upgrade
|
Effective Tax Rate | 128.77% | - | - | - | - | Upgrade
|
Revenue as Reported | - | - | - | - | 1,022 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.